Seattle Children’s opens CD22 CAR T-cell immunotherapy trial for … – Medical Xpress
|
Seattle Children's opens CD22 CAR T-cell immunotherapy trial for …
Medical Xpress After seeing promising results in phase 1 of the Pediatric Leukemia Adoptive Therapy (PLAT-02) trial with 93 percent of patients with relapsed or refractory acute … |
